EZH2 and neoplasm: The PRC2 catalytic subunit EZH2 has a tumor-promoting role in many malignancies, and inhibition of its activity or genetically induced loss of the protein strongly impairs tumor growth 43, 44, 45, 46, 47, 48, 49, 50.